The conference "From Tumor Biology to Future Clinical Solutions," organized by the MICC, aims to be the premier event for the cancer community in Israel, attracting the world’s leading cancer researchers. This event will bridge the gap between fundamental cancer research and clinical application, addressing the multifaceted nature of cancer.
The geopolitical situation in Israel in the past year has been extremely challenging. However, we continue to believe in the importance of science and our quest for scientific discoveries that could transform patient lives worldwide. Therefore, we have decided to relocate the event to Athens, Greece. To facilitate travel, the Weizmann Institute will provide financial support to a select number of students who submit abstracts. Please apply!
The conference "From Tumor Biology to Future Clinical Solutions," hosted by the MICC, is set to be the leading event for the cancer research community in Israel, drawing top cancer scientists from around the globe. The conference aims to bridge the divide between fundamental cancer research and its clinical applications, addressing the complex nature of cancer. It will delve into cancer as a systemic disease, focusing on the tumor microenvironment to shed light on the interactions between cancer and the immune system, as well as the genetic and epigenetic factors driving tumor development. Key sessions will explore drug resistance mechanisms, metastasis, and early diagnosis, emphasizing the current challenges and opportunities in cancer treatment. Additionally, discussions on tumor metabolism and cutting-edge therapeutic technologies will present innovative approaches to cancer care. This conference will promote the exchange of advanced research and foster collaborations, contributing to the advancement of novel clinical solutions for cancer treatment.
